Kizoo
Member organisation (sister of the Forever Healthy Foundation) Mira Holding
Also known as Kizoo Technology Capital, Kizoo Technology Ventures
German investment firm of Michael Greve, part of his Mira Holding group; provides seed and follow-on financing to rejuvenation biotech start-ups such as cellvie, Revel and Elastrin.
USEFUL FOR Founders · Co-investors
German investment firm owned by Michael Greve (founder of the Forever Healthy Foundation); a sister organisation of Forever Healthy within Mira Holding. Not a third-party fund.
Family & background
- FAMILY
- Greve (Michael Greve)
- WEALTH ORIGIN
- Technology ventures (per Greve's 2021 statement)
- HEADQUARTERS
- Germany
Investment approach
- SECTORS
- Biotech & Life Sciences
- GEOGRAPHY
- Global
- STAGES
- Seed
- ROUTES
- Companies (own capital)
- STRATEGIES
- Venture capitalDirect investments
Overview
Kizoo Technology Capital is the investment firm owned by Michael Greve, founder of the Forever Healthy Foundation; Forever Healthy describes Kizoo as its sister organisation within Mira Holding. Kizoo provides seed and follow-on financing focused on rejuvenation biotech, supporting start-ups that turn research on the root causes of aging into therapies. In 2021 Greve committed an additional €300 million, to be deployed via Kizoo, to rejuvenation biotech start-ups.
Investment thesis
Lighthouse investments in entirely new, repair-based approaches that treat the root causes of aging (e.g. removal of arterial plaque, decalcification of aged tissue, breaking of protein-glucose cross-links, delivery of new mitochondria to aged cells), with a multi-round commitment to key start-ups.
Holdings & investments (5)
INVESTMENT ARMS & VEHICLES
- Sister organisation in Mira Holding: private humanitarian initiative on extending healthy lifespan
HOLDINGS & INVESTMENTS · MOST RECENT FIRST
- Biotech & Life Sciences · since 2021
- Biotech & Life Sciences · since 2020
- Biotech & Life Sciences
- Biotech & Life Sciences
- Biotech & Life Sciences
People
Frequently asked questions
Kizoo is a single family office based in Germany.
Kizoo invests on behalf of the Greve (Michael Greve) family (Technology ventures (per Greve's 2021 statement)).
Kizoo invests directly in companies. Capital origin: one family's own capital. Stated strategies include venture capital and direct investments.
Kizoo invests at Seed stage in Biotech & Life Sciences.
Key people at Kizoo include Michael Greve (Owner) and Frank Schueler (Managing Director, Kizoo (2023)).
Kizoo's disclosed holdings and investments include Revel Pharmaceuticals, cellvie, Elastrin, Cyclarity and MoglingBio.
The most recent publicly reported investment by Kizoo is Revel Pharmaceuticals (USD 12M seed round (participation, alongside LongGame Ventures, Starbloom Capital and others)), announced in May 2026.